CA125 regression in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy: A gynecologic oncology group study

► An intensive CA125 monitoring schedule demonstrates a similar rate of CA125 normalization with IP versus IV treatment. ► Prognostic data to stratify subgroups most appropriate for novel consolidation or maintenance treatment strategies are identified.